Adamas Pharmaceuticals

ADMS

40.09

+1.90

+5.0%

Please Login or Register

Login|Register FREE

Stock Price
Open: 38.47
Prev. Close: 38.19
Low/Hi: 38.08 - 40.84
52-Week: 13.50 - 38.75
Volumes
Equity: 511,591
90-Day Avg: 954,373
Option: 2,964
90-Day Avg: 949
Volatility
Todays Stock Vol: 66.2
20-Day (HV): 63.0
52-Week (HV): 55.2
30-Day IV: 69.9 -4.7
IV Pct Rank: 79% Moderate
Fundamental
Div. Yield:
Earnings: 23-Feb (Est.)
P/E Ratio:
Market Cap: 869.9 M
Short Int Pct: 0.0%
Pct Held By Inst.: 97.3%
Stock Info
Type: Common
Sector: Healthcare
Industry: Drugs - Generic

ADMS Company Events

Upcoming Events
Event Event Date Location Info
No Upcoming Events
Past Events
Event Event Date Location Info
Global Mizuho Investor Conference Dec 5, 2017
Evercore ISI 2017 Biopharma Catalyst/Deep Dive Conference Nov 30, 2017
29th Annual Piper Jaffray Healthcare Conference Nov 28, 10:30 AM
Investor and Analyst Meeting Sep 18, 2017
New Drug Application supporting ADS-5102 PDUFA date Aug 24, 2017
JMP Securities 2017 Life Science Conference Jun 20, 11:30 AM
Jefferies 2017 Global Healthcare Conference Jun 6, 9:30 AM
69thAmerican Academy of Neurology (AAN) Annual Meeting Apr 22, 2017 - Apr 28, 2017
16th Annual Needham Healthcare Conference Apr 4, 10:40 AM
Academy of Managed Care Pharmacys (AMCP) 2017 Annual Meeting Mar 28, 2017
37th Annual Cowen Health Care Conference Mar 6, 2017
Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) Forum 2017 Feb 23, 2017
i

A Phase 2 Study of ADS-5102 (amantadine hydrochloride) Extended Release Capsules in Multiple Sclerosis Patients with Walking Impairment

28th Annual Piper Jaffray Healthcare Conference Nov 29, 9:30 AM
Stifel 2016 Healthcare Conference Nov 15, 2016
25th Annual Credit Suisse Healthcare Conference Nov 7, 10:00 AM
4th World Parkinson Congress (WPC) Sep 20, 2016 - Sep 23, 2016
Cantor Fitzgerald 2nd Annual Healthcare Conference Article Time: 06/29 4:05:00 PM Jul 12, 2016 New York
i

Gregory T. Went, Ph.D., Chairman and Chief Executive Officer of Adamas, will present

20th International Congress of Parkinsons and Movement Disorders Jun 22, 2016 - Jun 23, 2016 Berlin, Germany
i

trials from the companys Phase 3 clinical program of ADS-5102 for the treatment of levodopa-induced dyskinesia (LID) associated with Parkinsons disease, will be highlighted in two poster presentations

20th International Congress of Parkinsons and Movement Disorders Jun 19, 2016 - Jun 23, 2016 Berlin, Germany.
i

announced that data from EASE LID and EASE LID 2, trials from the companys Phase 3 clinical program of ADS-5102 for the treatment of levodopa-induced dyskinesia (LID) associated with Parkinsons disease, will be highlighted in two poster presentations

the 68th American Academy of Neurology Annual Meeting Apr 15, 2016 - Apr 21, 2016 Vancouver, British Columbia
i

present emerging science abstract # 014, ADS-5102 (amantadine HCl) Extended-Release Capsules Reduced Levodopa-Induced Dyskinesia in the Phase 3 EASE

15th Annual Needham Healthcare Conference Apr 12, 12:10 PM New York, NY
i

Gregory T. Went, Ph.D., Chairman and Chief Executive Officer of Adamas, will present

36th Annual Cowen and Company Healthcare Conference Mar 8, 10:40 AM Boston, MA
i

Gregory T. Went, Ph.D., Chairman and Chief Executive Officer of Adamas, will present

Conference Call and Webcast to Provide Company Update Dec 23, 2015
i

Gregory T. Went, Ph.D., Chairman and Chief Executive Officer of Adamas, will host a conference call and webcast on Wednesday, December 23, 2015, at 8:00 AM ET / 5:00 AM PT , to provide a company update

Webcast to Provide Company Update Dec 23, 2015
i

Gregory T. Went, Ph.D., Chairman and Chief Executive Officer of Adamas, will host a conference call

27th Annual Piper Jaffray Healthcare Conference Dec 2, 8:30 AM New York
i

Gregory T. Went, Ph.D., Chairman and Chief Executive Officer of Adamas, will present

24th Annual Credit Suisse Healthcare Conference Nov 10, 10:30 AM Scottsdale, Arizona
i

Gregory T. Went, Ph.D., Chairman and Chief Executive Officer of Adamas Pharmaceuticals, Inc., will present

31st Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) Oct 14, 2015 Barcelona, Spain
Biotech Industry Conference Sep 10, 2015 New York
2015 JMP Securities Life Science Conference in New York Jun 23, 2:30 PM
Needham Healthcare Conference Apr 14, 2015

Wait, Before You Leave...

Want to Know More About ADMS Earnings?

Receive your FREE email to get Wall Street expected earnings moves and daily upcoming earnings alerts!
Market Chameleon